GlassScriptPhysician profile
John Moxley Lee
NPI 1245276088
$11,223.95
in general payments reported to CMS, 2019-2025
67 companies · $641 in 2025
The $641 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,590 · 2020: $1,122 · 2021: $1,912 · 2022: $2,150 · 2023: $2,574 · 2024: $1,236 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,187 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,187.45 |
| Education | $262.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $995.56 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $990.32 | 2019-2025 | Farxiga, Airsupra, Fasenra |
| Novo Nordisk INC | $758.60 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Almatica Pharma LLC | $754.41 | 2021-2024 | Loreev Xr, Gralise |
| Axsome Therapeutics, INC. | $610.92 | 2023-2025 | Sunosi, Auvelity |
| Astellas Pharma US INC | $388.05 | 2021-2024 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $380.83 | 2021-2024 | Trelegy Ellipta |
| Amgen INC. | $344.28 | 2019-2024 | Otezla, Repatha |
| Kowa Pharmaceuticals America, INC. | $332.24 | 2019-2024 | Livalo, Seglentis |
| Lilly USA, LLC | $331.43 | 2019-2023 | Mounjaro |
| Teva Pharmaceuticals USA, INC. | $283.14 | 2019-2022 | |
| Allergan, INC. | $265.73 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $245.72 | 2021-2024 | |
| Amarin Pharma, INC. | $241.26 | 2019-2022 | |
| Pfizer INC. | $236.30 | 2019-2025 |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.